INMB   $1.27  3.25% Market Closed After Close 1.23 -3.15%

INmune Bio Inc.
Total Cash 33.55M
totalCashPerShare 1.513
EBITDA
Total Debt 2.91M
quickRatio 2.53
currentRatio 2.594
Total Revenue 42.00K
debtToEquity 7.532
Revenue/Share 0.002
ROA -0.44972
ROE -0.98964995
grossProfits
freeCashflow -10.76M
operatingCashflow -25.75M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -989.2143
profitMargins 0.0
enterpriseValue 106.61M
forwardPE -3.215
floatShares 14.31M
sharesOutstanding 22.17M
sharesShort 2.83M
sharesShortPriorMonth 3.16M
dateShortInterest
sharesPercentSharesOut 0.13%
heldPercentInsiders 0.29%
heldPercentInstitutions 0.21%
Short Ratio help_outline 9.32%
shortPercentOfFloat 0.16%
impliedSharesOutstanding
bookValue 1.744
Price To Book help_outline 3.69
earningsQuarterlyGrowth
netIncomeToCommon -41.27M
trailingEps -2.18%
forwardEps -2.00%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.55 4Q 2024
institutionsCount 83
lastUpdated Nov. 7, 2024, 2:58 a.m.